Label-free two-photon fluorescence lifetime imaging of FADH2 for rapid diagnosis and grading of glioma
Shiqi Wang, Yixuan Yang, Chaodong Yin, Jiaqing Guo, Yan Xu, Binglin Shen, Shijun Huang, Li Wang, Jie Chen, Shuai Ye, Zhang Hong, Jianqiang Li · 2026
Read Label-free two-photon fluorescence lifetime imaging of FADH2 for rapid diagnosis and grading of glioma by Shiqi Wang, Yixuan Yang, Chaodong Yin, Jiaqing Guo, Yan Xu, Binglin Shen, Shijun Huang, Li Wang, Jie Chen, Shuai Ye, Zhang Hong, Jianqiang Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13617214.txt.
Description
Shiqi Wang and thirteen colleagues develop a label-free imaging method that reads tumor metabolism to diagnose and grade glioma, the most aggressive common brain tumor. Standard diagnosis relies on tissue pathology, which shows cell shape but not the living metabolic landscape. Their system uses two-photon fluorescence lifetime imaging, which times how long molecules glow after laser pulses, mapped through phasor analysis.
The method revealed distinct hotspots rich in reduced flavin adenine dinucleotide, a metabolic molecule, and those niches lined up closely with deposits of collagen IV in the tumor surroundings. Imaging across four glioma subtypes separated tissue regions by metabolic pattern. Tracking tumors over time in a mouse model then showed the signatures could distinguish levels of malignancy. The authors propose the hotspots as an optical biomarker that could one day guide surgery in real time.
Catalog record
| CREATOR | Shiqi Wang, Yixuan Yang, Chaodong Yin, Jiaqing Guo, Yan Xu, Binglin Shen, Shijun Huang, Li Wang, Jie Chen, Shuai Ye, Zhang Hong, Jianqiang Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |